Molecules (Basel, Switzerland) · 2021
High-Throughput Fluorescent Assay for Inhibitor Screening of Proteases from RNA Viruses.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cihlova Bara, Huskova Andrea, Böserle Jiri, Nencka Radim, Boura Evzen, Silhan Jan
Аннотация
Spanish flu, polio epidemics, and the ongoing COVID-19 pandemic are the most profound examples of severe widespread diseases caused by RNA viruses. The coronavirus pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demands affordable and reliable assays for testing antivirals. To test inhibitors of viral proteases, we have developed an inexpensive high-throughput assay based on fluorescent energy transfer (FRET). We assayed an array of inhibitors for papain-like protease from SARS-CoV-2 and validated it on protease from the tick-borne encephalitis virus to emphasize its versatility. The reaction progress is monitored as loss of FRET signal of the substrate. This robust and reproducible assay can be used for testing the inhibitors in 96- or 384-well plates.
Предметные рубрики MeSH
Antiviral AgentsCoronavirus Papain-Like ProteasesDrug Evaluation, PreclinicalEncephalitis Viruses, Tick-BorneFluorescence Resonance Energy TransferFluorescent DyesHigh-Throughput Screening AssaysHumansProtease InhibitorsRNA HelicasesRNA VirusesSARS-CoV-2Serine EndopeptidasesViral Nonstructural ProteinsCOVID-19 Drug TreatmentNucleoside-TriphosphataseDEAD-box RNA HelicasesViral Proteases